Company profile AKBA
After 34 days of this quarter the interest is at 15.0. Based on that we can calculate that during remaining 58 days it will total up to 41.0. Akebia Therapeutics expected interest is significantly lower compared to previous quarter (-69.4%) and same quarter last year (-53.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 77 |
| 2019 | 153 98.7% QoQ | 184 20.3% QoQ | 198 7.6% QoQ | 217 181.8% YoY 9.6% QoQ |
| 2020 | 168 9.8% YoY -22.6% QoQ | 224 21.7% YoY 33.3% QoQ | 335 69.2% YoY 49.6% QoQ | 258 18.9% YoY -23.0% QoQ |
| 2021 | 276 64.3% YoY 7.0% QoQ | 242 8.0% YoY -12.3% QoQ | 167 -50.1% YoY -31.0% QoQ | 174 -32.6% YoY 4.2% QoQ |
| 2022 | 279 1.1% YoY 60.3% QoQ | 144 -40.5% YoY -48.4% QoQ | 116 -30.5% YoY -19.4% QoQ | 89 -48.9% YoY -23.3% QoQ |
| 2023 | 145 -48.0% YoY 62.9% QoQ | 121 -16.0% YoY -16.6% QoQ | 134 15.5% YoY 10.7% QoQ | 15 -83.1% YoY -88.8% QoQ |
The average 5 years interest of Akebia Therapeutics was 14.24 per week. The last year interest of Akebia Therapeutics compared to the last 5 years has changed by -37.08%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -30.54%.
After 39 days of this quarter the interest is at 58.0. Based on that we can calculate that during remaining 52 days it will total up to 135.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 99 | 66 -33.3% QoQ | 27 -59.1% QoQ | 68 151.9% QoQ |
| 2020 | 69 -30.3% YoY 1.5% QoQ | 42 -36.4% YoY -39.1% QoQ | 25 -7.4% YoY -40.5% QoQ | 114 67.6% YoY 356.0% QoQ |
| 2021 | 145 110.1% YoY 27.2% QoQ | 100 138.1% YoY -31.0% QoQ | 31 24.0% YoY -69.0% QoQ | 116 1.8% YoY 274.2% QoQ |
| 2022 | 123 -15.2% YoY 6.0% QoQ | 23 -77.0% YoY -81.3% QoQ | 91 193.5% YoY 295.7% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 169 37.4% YoY inf% QoQ | 112 387.0% YoY -33.7% QoQ | 29 -68.1% YoY -74.1% QoQ | 141 inf% YoY 386.2% QoQ |
| 2024 | 58 -65.7% YoY -58.9% QoQ | - | - | - |
The average 5 years interest of Vafseo was 6.31 per week. The last year interest of Vafseo compared to the last 5 years has changed by 33.44%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 33.02%.
After 39 days of this quarter the interest is at 143.0. Based on that we can calculate that during remaining 52 days it will total up to 334.0. Auryxia expected interest is significantly lower compared to previous quarter (-40.3%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 463 | 716 54.6% QoQ | 610 -14.8% QoQ | 698 14.4% QoQ |
| 2020 | 724 56.4% YoY 3.7% QoQ | 563 -21.4% YoY -22.2% QoQ | 712 16.7% YoY 26.5% QoQ | 638 -8.6% YoY -10.4% QoQ |
| 2021 | 772 6.6% YoY 21.0% QoQ | 695 23.4% YoY -10.0% QoQ | 630 -11.5% YoY -9.4% QoQ | 697 9.2% YoY 10.6% QoQ |
| 2022 | 652 -15.5% YoY -6.5% QoQ | 680 -2.2% YoY 4.3% QoQ | 676 7.3% YoY -0.6% QoQ | 575 -17.5% YoY -14.9% QoQ |
| 2023 | 533 -18.3% YoY -7.3% QoQ | 562 -17.4% YoY 5.4% QoQ | 514 -24.0% YoY -8.5% QoQ | 559 -2.8% YoY 8.8% QoQ |
| 2024 | 143 -73.2% YoY -74.4% QoQ | - | - | - |
The average 5 years interest of Auryxia was 49.09 per week. The last year interest of Auryxia compared to the last 5 years has changed by -19.33%. The interest for Auryxia is significantly decreasing. The last year interest is quite lower compared to 5 years ago. It has decreased by -25.23%.
After 39 days of this quarter the interest is at 48.0. Based on that we can calculate that during remaining 52 days it will total up to 112.0. Akebia Therapeutics stock expected interest is significantly lower compared to same quarter last year (-40.7%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 83 | 41 -50.6% QoQ | 171 317.1% QoQ | 201 17.5% QoQ |
| 2020 | 166 100.0% YoY -17.4% QoQ | 191 365.9% YoY 15.1% QoQ | 315 84.2% YoY 64.9% QoQ | 250 24.4% YoY -20.6% QoQ |
| 2021 | 447 169.3% YoY 78.8% QoQ | 206 7.9% YoY -53.9% QoQ | 155 -50.8% YoY -24.8% QoQ | 137 -45.2% YoY -11.6% QoQ |
| 2022 | 91 -79.6% YoY -33.6% QoQ | 104 -49.5% YoY 14.3% QoQ | 122 -21.3% YoY 17.3% QoQ | 94 -31.4% YoY -23.0% QoQ |
| 2023 | 189 107.7% YoY 101.1% QoQ | 123 18.3% YoY -34.9% QoQ | 99 -18.9% YoY -19.5% QoQ | 96 2.1% YoY -3.0% QoQ |
| 2024 | 48 -74.6% YoY -50.0% QoQ | - | - | - |
The average 5 years interest of Akebia Therapeutics stock was 12.75 per week. The last year interest of Akebia Therapeutics stock compared to the last 5 years has changed by -35.14%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -16.3%.
After 34 days of this quarter the interest is at 290.0. Based on that we can calculate that during remaining 58 days it will total up to 785.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 100 |
| 2019 | 360 260.0% QoQ | 327 -9.2% QoQ | 478 46.2% QoQ | 457 357.0% YoY -4.4% QoQ |
| 2020 | 433 20.3% YoY -5.3% QoQ | 382 16.8% YoY -11.8% QoQ | 560 17.2% YoY 46.6% QoQ | 431 -5.7% YoY -23.0% QoQ |
| 2021 | 356 -17.8% YoY -17.4% QoQ | 553 44.8% YoY 55.3% QoQ | 412 -26.4% YoY -25.5% QoQ | 533 23.7% YoY 29.4% QoQ |
| 2022 | 586 64.6% YoY 9.9% QoQ | 656 18.6% YoY 11.9% QoQ | 493 19.7% YoY -24.8% QoQ | 621 16.5% YoY 26.0% QoQ |
| 2023 | 642 9.6% YoY 3.4% QoQ | 659 0.5% YoY 2.6% QoQ | 594 20.5% YoY -9.9% QoQ | 290 -53.3% YoY -51.2% QoQ |
The average 5 years interest of Chronic kidney disease treatment was 38.17 per week. The last year interest of Chronic kidney disease treatment compared to the last 5 years has changed by 27.67%. The interest for Chronic kidney disease treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 73.42%.
After 39 days of this quarter the interest is at 396.0. Based on that we can calculate that during remaining 52 days it will total up to 924.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 581 | 824 41.8% QoQ | 751 -8.9% QoQ | 779 3.7% QoQ |
| 2020 | 822 41.5% YoY 5.5% QoQ | 767 -6.9% YoY -6.7% QoQ | 784 4.4% YoY 2.2% QoQ | 859 10.3% YoY 9.6% QoQ |
| 2021 | 894 8.8% YoY 4.1% QoQ | 902 17.6% YoY 0.9% QoQ | 790 0.8% YoY -12.4% QoQ | 833 -3.0% YoY 5.4% QoQ |
| 2022 | 1069 19.6% YoY 28.3% QoQ | 993 10.1% YoY -7.1% QoQ | 916 15.9% YoY -7.8% QoQ | 945 13.4% YoY 3.2% QoQ |
| 2023 | 1141 6.7% YoY 20.7% QoQ | 1039 4.6% YoY -8.9% QoQ | 974 6.3% YoY -6.3% QoQ | 1126 19.2% YoY 15.6% QoQ |
| 2024 | 396 -65.3% YoY -64.8% QoQ | - | - | - |
The average 5 years interest of Anemia treatment was 69.67 per week. The last year interest of Anemia treatment compared to the last 5 years has changed by 15.66%. The interest for Anemia treatment is relatively stable and increasing in the last 5 years. The last year interest is quite higher compared to 5 years ago. It has increased by 28.5%.
After 39 days of this quarter the interest is at 419.0. Based on that we can calculate that during remaining 52 days it will total up to 978.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 508 | 801 57.7% QoQ | 843 5.2% QoQ | 869 3.1% QoQ |
| 2020 | 821 61.6% YoY -5.5% QoQ | 791 -1.2% YoY -3.7% QoQ | 808 -4.2% YoY 2.1% QoQ | 796 -8.4% YoY -1.5% QoQ |
| 2021 | 886 7.9% YoY 11.3% QoQ | 863 9.1% YoY -2.6% QoQ | 830 2.7% YoY -3.8% QoQ | 839 5.4% YoY 1.1% QoQ |
| 2022 | 1039 17.3% YoY 23.8% QoQ | 949 10.0% YoY -8.7% QoQ | 920 10.8% YoY -3.1% QoQ | 880 4.9% YoY -4.3% QoQ |
| 2023 | 1053 1.3% YoY 19.7% QoQ | 980 3.3% YoY -6.9% QoQ | 969 5.3% YoY -1.1% QoQ | 1029 16.9% YoY 6.2% QoQ |
| 2024 | 419 -60.2% YoY -59.3% QoQ | - | - | - |
The average 5 years interest of Iron deficiency anemia was 68.56 per week. The last year interest of Iron deficiency anemia compared to the last 5 years has changed by 11.95%. The interest for Iron deficiency anemia is relatively stable in the last 5 years. The last year interest is quite higher compared to 5 years ago. It has increased by 19.6%.
There is not enough data for Phosphorus control in CKD to provide analysis
There is not enough data for Phosphorus control in CKD to provide correlation calculation
There is not enough data for Phosphorus control in CKD to provide analysis
After 39 days of this quarter the interest is at 39.0. Based on that we can calculate that during remaining 52 days it will total up to 91.0. Vadadustat expected interest is significantly higher compared to previous quarter (+333.3%) and same quarter last year (+42.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 23 | 27 17.4% QoQ | 41 51.9% QoQ | 61 48.8% QoQ |
| 2020 | 84 265.2% YoY 37.7% QoQ | 48 77.8% YoY -42.9% QoQ | 125 204.9% YoY 160.4% QoQ | 47 -23.0% YoY -62.4% QoQ |
| 2021 | 64 -23.8% YoY 36.2% QoQ | 102 112.5% YoY 59.4% QoQ | 23 -81.6% YoY -77.5% QoQ | 57 21.3% YoY 147.8% QoQ |
| 2022 | 193 201.6% YoY 238.6% QoQ | 153 50.0% YoY -20.7% QoQ | 42 82.6% YoY -72.5% QoQ | 60 5.3% YoY 42.9% QoQ |
| 2023 | 64 -66.8% YoY 6.7% QoQ | 61 -60.1% YoY -4.7% QoQ | 62 47.6% YoY 1.6% QoQ | 21 -65.0% YoY -66.1% QoQ |
| 2024 | 39 -39.1% YoY 85.7% QoQ | - | - | - |
The average 5 years interest of Vadadustat was 5.35 per week. The last year interest of Vadadustat compared to the last 5 years has changed by -21.68%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 3.71%.
There is not enough data for Akebia Therapeutics collaboration to provide analysis
There is not enough data for Akebia Therapeutics collaboration to provide correlation calculation
There is not enough data for Akebia Therapeutics collaboration to provide analysis